About
Diabeloop is a French company founded in 2015 that focuses on AI-based solutions for diabetes management. The company aims to improve clinical outcomes and quality of life for individuals with Type 1 and Type 2 diabetes. Diabeloop combines expertise in medical research, technology design, and algorithm development to create innovative therapeutic products. The flagship product, the DBLG1 System, is a hybrid closed-loop automated insulin delivery system. It uses a self-learning algorithm to monitor glucose levels and administer personalized insulin doses every five minutes. This system reduces the mental burden of diabetes management by adapting insulin delivery based on real-time data and individual patient needs. Diabeloop also offers the DBL-hu solution for unstable Type 1 diabetes and the DBL-4pen app for integrating insulin pens. The company emphasizes usability and patient-centered features, such as Zen Mode and Privacy Mode, to enhance user experience. With over 160 employees, Diabeloop has secured significant funding and is expanding its reach across Europe, with plans for international rollout, including the U.S. market.
Technologies
Keywords
Company Information
- Employees68
- Founded2015
- Annual Revenue$2000000
- Total Funding$125359158
Location
17 Rue Felix Esclangon, Grenoble, Auvergne-Rhone-Alpes, France, 38000
